# Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/investigational-new-drug-applications-for-positron-emission-tomography-pet-drugs/c3d2d63b-b192-4684-b9ea-880c5065d37b

> FDA guidance document: Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs. Issue date: December 03, 2012. Get complete insights and analysis.

---

## Details

- Title: Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2012-12-03
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2012-D-0081">FDA-2012-D-0081</a>

## Related Documents

- [FDA Oversight of PET Drug Products -- Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/fda-oversight-of-pet-drug-products-questions-and-answers/3e894e01-dc7a-4e5e-a828-a0b032a0404f)
- [Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography](https://www.globalkeysolutions.net/guidances/guidance-document/media-fills-for-validation-of-aseptic-preparations-for-positron-emission-tomography/517018b5-dd39-40a9-a516-f826a28553a7)
- [Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications](https://www.globalkeysolutions.net/guidances/guidance-document/submission-of-summary-bioequivalence-data-for-abbreviated-new-drug-applications/c8804eda-e868-4190-aaf3-700e3b13cf9e)
